1127 | Humans |
646 | Female |
529 | Male |
386 | Middle Aged |
337 | Adult |
301 | Aged |
204 | Animals |
159 | Risk Factors |
156 | Treatment Outcome |
144 | Adolescent |
138 | Young Adult |
131 | Genetic Predisposition to Disease |
124 | Polymorphism, Single Nucleotide |
107 | Child |
100 | Genome-Wide Association Study |
95 | Aged, 80 and over |
92 | Europe |
91 | Case-Control Studies |
88 | Mutation |
82 | Breast Neoplasms |
80 | Prospective Studies |
75 | Prognosis |
74 | Genotype |
73 | Time Factors |
69 | Child, Preschool |
68 | Cohort Studies |
67 | Follow-Up Studies |
59 | Infant |
56 | Phenotype |
51 | Double-Blind Method |
50 | Risk Assessment |
49 | Practice Guidelines as Topic |
49 | Age Factors |
48 | Genetic Variation |
47 | Retrospective Studies |
46 | European Continental Ancestry Group |
44 | Consensus |
42 | Incidence |
42 | Global Health |
42 | Australia |
41 | Risk |
41 | Biomarkers |
40 | Phylogeny |
40 | Mice |
40 | Antineoplastic Combined Chemotherapy Protocols |
39 | Randomized Controlled Trials as Topic |
39 | Disease Progression |
38 | Severity of Illness Index |
38 | Reproducibility of Results |
38 | Proportional Hazards Models |
37 | Neoplasm Staging |
37 | Disease-Free Survival |
36 | Ovarian Neoplasms |
36 | Alleles |
35 | Survival Rate |
35 | Neoplasms |
35 | Antineoplastic Agents |
34 | Societies, Medical |
34 | International Cooperation |
34 | Brain |
33 | United States |
33 | Pregnancy |
33 | Infant, Newborn |
32 | Registries |
32 | Kaplan-Meier Estimate |
32 | Genetic Loci |
32 | Genetic Association Studies |
31 | Signal Transduction |
31 | Biodiversity |
30 | Surveys and Questionnaires |
30 | Odds Ratio |
30 | Magnetic Resonance Imaging |
29 | Terminology as Topic |
29 | Sequence Analysis, DNA |
29 | Prevalence |
29 | Ecosystem |
28 | Drug Therapy, Combination |
27 | Genome, Human |
26 | Genomics |
26 | Evolution, Molecular |
26 | Clinical Trials as Topic |
25 | Research Design |
25 | Quantitative Trait Loci |
25 | Quality of Life |
24 | Survival Analysis |
24 | Drug Administration Schedule |
24 | Cardiovascular Diseases |
23 | Computational Biology |
23 | Chromosome Mapping |
22 | Predictive Value of Tests |
22 | Multivariate Analysis |
22 | Molecular Sequence Data |
22 | Evidence-Based Medicine |
22 | Body Mass Index |
21 | Internationality |
21 | High-Throughput Nucleotide Sequencing |
21 | Hematopoietic Stem Cell Transplantation |
21 | Exome |
21 | Disease Management |
21 | Cross-Sectional Studies |
21 | Conservation of Natural Resources |
21 | Algorithms |
20 | United Kingdom |
20 | Stroke |
20 | Prostatic Neoplasms |
20 | Haplotypes |
20 | Gene Expression Profiling |
19 | Recurrence |
19 | Pedigree |
19 | Melanoma |
19 | HIV Infections |
19 | Gene Expression Regulation |
19 | DNA Mutational Analysis |
18 | Models, Theoretical |
18 | Logistic Models |
18 | Heart Failure |
18 | Base Sequence |
18 | Amino Acid Sequence |
17 | Protein Kinase Inhibitors |
17 | Models, Biological |
17 | Guidelines as Topic |
17 | Diabetes Mellitus, Type 2 |
17 | Colorectal Neoplasms |
16 | Skin Neoplasms |
16 | Sex Factors |
16 | Outcome Assessment (Health Care) |
16 | Neoplasm Recurrence, Local |
16 | Neoplasm Metastasis |
16 | Myocardial Infarction |
16 | Meta-Analysis as Topic |
16 | Lung Neoplasms |
16 | Longitudinal Studies |
16 | Hospitalization |
16 | Genetics, Population |
16 | Cell Line, Tumor |
16 | Blood Pressure |
16 | Biomarkers, Tumor |
16 | Biological Evolution |
16 | Bayes Theorem |
16 | Aging |
15 | Heterozygote |
15 | Genetic Testing |
15 | Gene Frequency |
15 | Exercise |
15 | Databases, Factual |
15 | Cause of Death |
15 | Asthma |
14 | Smoking |
14 | Sensitivity and Specificity |
14 | Recombinant Proteins |
14 | Intellectual Disability |
14 | France |
14 | Dose-Response Relationship, Drug |
14 | Disease Models, Animal |
14 | Climate Change |
14 | BRCA1 Protein |
14 | Arthritis, Rheumatoid |
14 | Antiviral Agents |
14 | Age Distribution |
13 | Species Specificity |
13 | Software |
13 | Sex Distribution |
13 | Neoplasms, Glandular and Epithelial |
13 | Neoplasm Grading |
13 | Models, Statistical |
13 | Germ-Line Mutation |
13 | Gene Expression Regulation, Neoplastic |
13 | Diet |
13 | Comorbidity |
13 | Cognition |
13 | Carbon Dioxide |
13 | Antibodies, Monoclonal |
13 | Antibodies, Monoclonal, Humanized |
13 | Anti-Bacterial Agents |
13 | Age of Onset |
12 | Vaccination |
12 | Obesity |
12 | Mutation, Missense |
12 | Models, Molecular |
12 | Hypoglycemic Agents |
12 | Epigenesis, Genetic |
12 | Databases, Genetic |
12 | Combined Modality Therapy |
12 | Cell Line |
12 | Blood Glucose |
12 | Biomedical Research |
12 | Asian Continental Ancestry Group |
12 | Alzheimer Disease |
11 | Tumor Suppressor Proteins |
11 | Trees |
11 | Transcription Factors |
11 | ROC Curve |
11 | RNA, Messenger |
11 | Pyrimidines |
11 | Proteins |
11 | Prosthesis Design |
11 | Population Dynamics |
11 | Nuclear Proteins |
11 | New Zealand |
11 | Neuropsychological Tests |
11 | Mortality |
11 | Models, Genetic |
11 | International Agencies |
11 | Hepatitis C, Chronic |
11 | HEK293 Cells |
11 | Geography |
11 | Endometrial Neoplasms |
11 | Electrocardiography |
11 | Datasets as Topic |
11 | DNA Copy Number Variations |
11 | Cooperative Behavior |
11 | Computer Simulation |
11 | Cognition Disorders |
11 | Climate |
11 | Cholesterol, LDL |
11 | Cells, Cultured |
11 | Carbon |
10 | Tuberculosis |
10 | Transplantation Conditioning |
10 | Renal Insufficiency, Chronic |
10 | Remission Induction |
10 | Regression Analysis |
10 | Receptor, ErbB-2 |
10 | Postoperative Complications |
10 | Plasmodium falciparum |
10 | Mice, Inbred C57BL |
10 | Membrane Proteins |
10 | Malaria |
10 | Immunosuppressive Agents |
10 | Imidazoles |
10 | Hemorrhage |
10 | Gene Expression |
10 | DNA, Mitochondrial |
10 | Cost-Benefit Analysis |
10 | Coronary Artery Disease |
9 | Viral Load |
9 | Tropical Climate |
9 | Temperature |
9 | Selection, Genetic |
9 | Ribavirin |
9 | Reproduction |
9 | Receptors, Estrogen |
9 | Rats |
9 | Promoter Regions, Genetic |
9 | Polyethylene Glycols |
9 | Papillomavirus Infections |
9 | Molecular Sequence Annotation |
9 | Menopause |
9 | Mendelian Randomization Analysis |
9 | Liver Cirrhosis, Biliary |
9 | Information Dissemination |
9 | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
9 | Hospital Mortality |
9 | Genome, Bacterial |
9 | Genes, BRCA2 |
9 | Extinction, Biological |
9 | Environment |
9 | Drug Combinations |
9 | Diabetes Mellitus |
9 | DNA |
9 | DNA-Binding Proteins |
9 | Critical Illness |
9 | Cost of Illness |
9 | Chemotherapy, Adjuvant |
9 | Cattle |
9 | Carrier Proteins |
9 | Asia |
9 | Antifungal Agents |
9 | Anticholesteremic Agents |
9 | Acute Disease |
9 | Acute Coronary Syndrome |
8 | World Health Organization |
8 | Water |
8 | Sulfonamides |
8 | Soil |
8 | Seasons |
8 | Schizophrenia |
8 | Rheumatology |
8 | Reference Standards |
8 | Rare Diseases |
8 | Precision Medicine |
8 | Postmenopause |
8 | Platelet Aggregation Inhibitors |
8 | Pilot Projects |
8 | Phylogeography |
8 | Percutaneous Coronary Intervention |
8 | Pancreatic Neoplasms |
8 | Observational Studies as Topic |
8 | Nerve Tissue Proteins |
8 | Molecular Targeted Therapy |
8 | Liver Neoplasms |
8 | Liver Cirrhosis |
8 | Interferon-alpha |
8 | Intensive Care Units |
8 | Insulin |
8 | In Situ Hybridization, Fluorescence |
8 | Hypertension |
8 | History, Ancient |
8 | Hippocampus |
8 | Hepacivirus |
8 | Health Services Accessibility |
8 | Genome |
8 | Genome, Plant |
8 | Genes, BRCA1 |
8 | Gene Dosage |
8 | Forced Expiratory Volume |
8 | Exons |
8 | Enzyme-Linked Immunosorbent Assay |
8 | Enhancer Elements, Genetic |
8 | Echocardiography |
8 | Early Detection of Cancer |
8 | Diagnosis, Differential |
8 | Developing Countries |
8 | Dementia |
8 | DNA Methylation |
8 | Cholangitis |
8 | Cerebral Hemorrhage |
8 | Cell Proliferation |
8 | Carcinoma |
8 | Canada |
8 | Bipolar Disorder |
8 | BRCA2 Protein |
8 | Atmosphere |
8 | Antihypertensive Agents |
8 | Administration, Oral |
8 | Adaptation, Physiological |
7 | Zebrafish |
7 | Transplantation, Homologous |
7 | Transcriptome |
7 | Stents |
7 | Statistics as Topic |
7 | Socioeconomic Factors |
7 | Sequence Alignment |
7 | Secondary Prevention |
7 | Seawater |
7 | Quinazolines |
7 | Quality Control |
7 | Pyridones |
7 | Pyridines |
7 | Pulmonary Disease, Chronic Obstructive |
7 | Protozoan Proteins |
7 | Proto-Oncogene Proteins B-raf |
7 | Protein Binding |
7 | Population Surveillance |
7 | Polymerase Chain Reaction |
7 | Patient Selection |
7 | Organ Size |
7 | Observer Variation |
7 | Netherlands |
7 | Neoplasm Invasiveness |
7 | Medical Oncology |
7 | Mass Screening |
7 | MCF-7 Cells |
7 | Kidney Neoplasms |
7 | Internet |
7 | Immunohistochemistry |
7 | Image Processing, Computer-Assisted |
7 | Hyperlipoproteinemia Type II |
7 | Huntington Disease |
7 | Homeodomain Proteins |
7 | Heart Valve Prosthesis |
7 | Germany |
7 | Genotyping Techniques |
7 | Genetic Markers |
7 | Fossils |
7 | Forests |
7 | Exercise Test |
7 | Epilepsy |
7 | Environmental Monitoring |
7 | Delphi Technique |
7 | Chronic Disease |
7 | Cardiology |
7 | Carcinoma, Renal Cell |
7 | Brain Neoplasms |
7 | Bone Density Conservation Agents |
7 | Autoimmune Diseases |
7 | Atrial Fibrillation |
7 | Area Under Curve |
7 | Apoptosis |
7 | Allergens |
7 | Adiposity |
7 | Adaptor Proteins, Signal Transducing |
6 | Vitamin D |
6 | Uterine Cervical Neoplasms |
6 | Triglycerides |
6 | Travel |
6 | Transcription, Genetic |
6 | Tomography, X-Ray Computed |
6 | Taste |
6 | Spain |
6 | Salvage Therapy |
6 | Research |
6 | Recombinant Fusion Proteins |
6 | Quality-Adjusted Life Years |
6 | Pyrazoles |
6 | Protein Conformation |
6 | Pregnancy Complications |
6 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
6 | Plants |
6 | Peritoneal Neoplasms |
6 | Perindopril |
6 | Papillomavirus Vaccines |
6 | Palliative Care |
6 | Oligopeptides |
6 | Occupational Exposure |
6 | North America |
6 | Muscles |
6 | Muscle, Skeletal |
6 | Multiple Sclerosis |
6 | Mitochondria |
6 | Lupus Erythematosus, Systemic |
6 | Lung |
6 | Linkage Disequilibrium |
6 | Leukemia, Lymphocytic, Chronic, B-Cell |
6 | Injections, Subcutaneous |
6 | Inflammation |
6 | Indoles |
6 | Image Interpretation, Computer-Assisted |
6 | Hypertension, Pulmonary |
6 | Hemoglobin A, Glycosylated |
6 | HLA Antigens |
6 | Grassland |
6 | Glomerular Filtration Rate |
6 | Glioma |
6 | Gene Regulatory Networks |
6 | Fluorouracil |
6 | Fishes |
6 | Fatigue |
6 | Estrogen Receptor alpha |
6 | Equipment Design |
6 | Environmental Exposure |
6 | Educational Status |
6 | Drug-Eluting Stents |
6 | Drug Resistance, Neoplasm |
6 | Diabetes Mellitus, Type 1 |
6 | Developed Countries |
6 | Dermatitis, Atopic |
6 | Databases, Protein |
6 | DNA Transposable Elements |
6 | Coronary Thrombosis |
6 | Continental Population Groups |
6 | Cognitive Dysfunction |
6 | Cluster Analysis |
6 | Clinical Trials, Phase III as Topic |
6 | Clinical Decision-Making |
6 | Cholesterol, HDL |
6 | Carcinoma, Hepatocellular |
6 | Carbon Cycle |
6 | Camptothecin |
6 | Brain Ischemia |
6 | Bone Neoplasms |
6 | Biomass |
6 | Binding Sites |
6 | Bacterial Proteins |
6 | Athletic Injuries |
6 | Athletes |
6 | Arrhythmias, Cardiac |
6 | Aortic Valve |
6 | Antirheumatic Agents |
6 | Antineoplastic Agents, Hormonal |
6 | Antimalarials |
6 | Anti-HIV Agents |
6 | Alternative Splicing |
6 | Alcohol Drinking |
6 | Agriculture |
6 | Adenocarcinoma |
5 | Wings, Animal |
5 | Vital Capacity |
5 | Up-Regulation |
5 | Ubiquitin-Protein Ligases |
5 | Tumor Suppressor Protein p53 |
5 | Triazoles |
5 | Trastuzumab |
5 | Tomography, Optical Coherence |
5 | Thyroid Neoplasms |
5 | Telomere Homeostasis |
5 | T-Lymphocytes |
5 | Syndrome |
5 | Sports |
5 | Sports Medicine |
5 | Sjogren's Syndrome |
5 | Sirolimus |
5 | Sex Characteristics |
5 | Sequence Homology, Amino Acid |
5 | Rituximab |
5 | Rhinitis, Allergic |
5 | Rheumatic Diseases |
5 | Respiration, Artificial |
5 | Repressor Proteins |
5 | Renal Dialysis |
5 | Reference Values |
5 | Real-Time Polymerase Chain Reaction |
5 | RNA, Viral |
5 | Quinolines |
5 | Quality of Health Care |
5 | Pyrimidinones |
5 | Pulmonary Medicine |
5 | Public Health |
5 | Proteomics |
5 | Protein Isoforms |